心臟自主神經控制市場：依產品類型、應用、最終用戶、地區

全球心臟自主控制市場預計將從2023年的168.4億美元增加到2030年的277.6億美元，複合年成長率為7.4%。

圖 1. 2023 年依地區分類的心臟自主控制全球市場佔有率(%)

全球心臟自主控制市場是更廣泛的醫療保健產業中快速發展的部分。該市場包括各種旨在監測、診斷和治療與心臟自主控制相關的疾病的產品和服務。心臟自主控制是一個複雜的過程，涉及中樞神經系統 (cANS) 對心率、血壓和其他心血管系統功能的調節。該系統在維持心血管穩態和響應身體生理狀態的變化方面發揮著重要作用。心臟自主控制市場包括各種診斷設備、治療設備和相關服務。心率監測器、血壓計和心電圖 (ECG) 機等診斷設備用於評估 CANS 功能並檢測異常情況。起搏器和植入式心臟整流去顫器(ICD) 等治療設備用於治療與心臟自主控制相關的疾病。該市場的推動因素包括心血管疾病盛行率的增加、醫療技術的進步以及人們對維持心血管健康重要性的認知不斷提高。但市場也面臨高成本、法規要求嚴格等課題。總體而言，在醫療保健需求增加和技術進步的推動下，全球心臟自主控制市場預計將在未來幾年顯著成長。

市場動態：

心血管疾病盛行率的增加、醫療技術的進步以及人們對心臟健康意識的提高預計將在預測期內推動全球心臟自主控制市場的成長。此外，人工智慧和機器學習的整合預計也將在預測期內推動全球心臟自主控制市場的成長。技術進步、個人化醫療、遠端患者監護和巨量資料分析預計將在預測期內為全球心臟自主控制市場提供成長機會。

然而，高成本、有限的意識和教育、複雜的監管環境以及資料隱私和安全問題預計將阻礙預測期內全球心臟自主控制市場的成長。

本研究的主要特點

• 該研究報告對全球心臟自主神經系統控制市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
• 它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球心臟自主控制市場的主要企業。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 全球心臟自主控制市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球心臟自主控制市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與假設

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
• 醫療科技的進步
• 人們對心臟健康的認知不斷增強
• 整合人工智慧和機器學習
• 個人化醫療
• 遠端患者監護
• 巨量資料分析
• 與遠端醫療整合
• 遠端患者監護
• 人工智慧和機器學習
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章全球心臟自主控制市場 -冠狀病毒(COVID-19) 大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章全球心臟自主神經控制市場，依產品類型，2018-2030

• 心率變異性 (HRV) 監測器
• 血壓計
• 心電監視器
• 其他

第6章 全球心臟自主神經系統控制市場，依應用分類，2018-2030

• 診斷
• 治療
• 研究

第 7 章 全球心臟自主控制市場，依最終使用者分類，2018-2030 年

• 醫院和診所
• 家庭用戶
• 調查機構
• 其他

第8章2018-2030年全球心臟自主神經控制市場（依地區）

• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• GCC
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第9章競爭形勢

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik
• MicroPort Scientific Corporation
• LivaNova PLC
• Nihon Kohden Corporation
• Schiller AG
• Johnson & Johnson
• GE Healthcare
• Fitbit
• BIOTRONIK
• Biobit
• InBody

第10章

• 調查方法
• 關於出版商

Global cardiac autonomic control market is estimated to reach US$ 27.76 bn by 2030, from US$ 16.84 bn in 2023, at a CAGR of 7.4%.

Figure 1. Global Cardiac Autonomic Control Market Share (%), By Region, 2023

The global cardiac autonomic control market is a rapidly evolving sector within the broader healthcare industry. This market encompasses a range of products and services designed to monitor, diagnose, and treat conditions related to the autonomic control of the heart. The autonomic control of the heart is a complex process that involves the regulation of heart rate, blood pressure, and other cardiovascular functions by the central autonomic nervous system (cANS). This system plays a crucial role in maintaining cardiovascular homeostasis and responding to changes in the body's physiological state. The cardiac autonomic control market includes various diagnostic devices, therapeutic devices, and related services. Diagnostic devices such as heart rate monitors, blood pressure monitors, and electrocardiogram (ECG) machines are used to assess the functioning of the cANS and detect abnormalities. Therapeutic devices such as pacemakers and implantable cardioverter defibrillators (ICDs) are used to treat conditions related to autonomic control of the heart. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in medical technology, and growing awareness about the importance of maintaining cardiovascular health. However, the market also faces challenges such as high costs of devices and stringent regulatory requirements. Overall, the global cardiac autonomic control market is expected to witness significant growth in the coming years, driven by increasing healthcare needs and technological advancements.

Market Dynamics:

Increasing prevalence of cardiovascular diseases, advancements in medical technology, and growing awareness about heart health are expected to drive growth of the global cardiac autonomic control market over the forecast period. Moreover, integration of artificial intelligence and machine learning is also expected to boost growth of the global cardiac autonomic control market over the forecast period. Technological advancements, personalized medicine, remote patient monitoring, and big data analytics are expected to create growth opportunities for the global cardiac autonomic control market during the forecast period.

However, high costs, limited awareness and education, complex regulatory landscape, and data privacy and security concerns are expected to hamper growth of the global cardiac autonomic control market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global cardiac autonomic control market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cardiac autonomic control market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, LivaNova PLC, Nihon Kohden Corporation, Schiller AG, Johnson & Johnson, GE Healthcare, Fitbit, BIOTRONIK, Biobit, InBody
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cardiac autonomic control market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac autonomic control market

Detailed Segmentation:

• Global Cardiac Autonomic Control Market, By Product Type:
  • Heart Rate Variability (HRV) Monitors
  • Blood Pressure Monitors
  • ECG Monitors
  • Others
• Global Cardiac Autonomic Control Market, By Application:
  • Diagnostics
  • Therapeutics
  • Research
• Global Cardiac Autonomic Control Market, By End User:
  • Hospitals and Clinics
  • Home Users
  • Research Institutes
  • Others
• Global Cardiac Autonomic Control Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Nihon Kohden Corporation
  • Schiller AG
  • Johnson & Johnson
  • GE Healthcare
  • Fitbit
  • BIOTRONIK
  • Biobit
  • InBody

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Cardiac Autonomic Control Market , By Product Type
  • Cardiac Autonomic Control Market , By Application
  • Cardiac Autonomic Control Market , By End User
  • Cardiac Autonomic Control Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Advancements in Medical Technology
• Growing Awareness about Heart Health
• Integration of Artificial Intelligence and Machine Learning
  • Restraints
• Personalized Medicine
• Remote Patient Monitoring
• Big Data Analytics
  • Opportunities
• Integration with Telehealth
• Remote Patient Monitoring
• Artificial Intelligence and Machine Learning
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Cardiac Autonomic Control Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cardiac Autonomic Control Market, By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Heart Rate Variability (HRV) Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Blood Pressure Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Bn)
• ECG Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Cardiac Autonomic Control Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Cardiac Autonomic Control Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
• Home Users
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)

8. Global Cardiac Autonomic Control Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotronik
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nihon Kohden Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Schiller AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fitbit
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BIOTRONIK
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biobit
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• InBody
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us